Skip to main content
logo
NextCell Pharma AB (STO:NXTCL)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.2865
+0.0330 (13.02%)
Nov 3, 2026, 5:25 PM CET

NextCell Pharma AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Aug '25 Aug '24 Aug '23 Aug '22
Market Capitalization
368113093124218
Market Cap Growth
-64.04%-37.52%40.40%-25.00%-43.31%-56.21%
Enterprise Value
15431147261111
Last Close Price
0.290.731.171.273.606.35

Price Ratios

Fiscal Year
CurrentFY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Aug '25 Aug '24 Aug '23 Aug '22
PS Ratio
3.368.2811.788.238.8735.05
PB Ratio
0.771.611.961.371.631.89
P/TBV Ratio
0.771.611.961.371.631.89

EV Ratios

Fiscal Year
CurrentFY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Aug '25 Aug '24 Aug '23 Aug '22
EV/Sales Ratio
1.404.3410.276.394.3417.86

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Aug '25 Aug '24 Aug '23 Aug '22
Net Debt / Equity Ratio
-0.45-0.51-0.58-0.69-0.66-0.84
Net Debt / EBITDA Ratio
0.530.701.161.111.232.81
Net Debt / FCF Ratio
0.460.560.901.241.042.37
Asset Turnover
--0.140.130.130.04
Inventory Turnover
--17.2422.7914.12-
Quick Ratio
3.683.928.055.065.3214.40
Current Ratio
3.715.1610.026.156.6715.40
Return on Equity (ROE)
---52.46%-58.55%-41.63%-26.02%
Return on Assets (ROA)
---28.39%-31.72%-24.01%-15.62%
Return on Capital Employed (ROCE)
-81.00%-70.60%-50.30%-60.50%-52.10%-29.80%

Yields

Fiscal Year
CurrentFY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Aug '25 Aug '24 Aug '23 Aug '22
Earnings Yield
-116.29%-47.64%-26.96%-45.20%-32.17%-15.83%
FCF Yield
-127.89%-57.20%-33.03%-40.79%-38.72%-18.74%
Buyback Yield / Dilution
-80.95%--87.22%-18.72%--13.05%